Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Prof. Artur Evangelista Masip
The highlight session focus on advances in aortic stenosis included five presentations which cover all aspects from aetiology to surgical management.
Bicuspid aortic valve is one of the most common causes of aortic stenosis. Amelia Carro et al analysed the results of echo familial screening in bicuspid aortic valve. The prevalence of bicuspid valve in the first degree relatives was 7% and the families with another bicuspid case were 19%. A surprising result of the study is that in 30% of cases, the valve phenotype was different within the family. This data may imply significant information for understanding the genetic bases of this disease.
In another communication Lin et al showed that the LV remodelling of AS in patients with different body mass index was similar from underweight to obese patients. A multicentre Japanese study proposes a new echocardiographic parameter to improve the prognosis value of this technique respect to events in the follow-up. This parameter can improve the risk stratification of patients with severe AS.
Sato et al show the advantages to quantify the AVA by 3D-echo compare with classical Doppler approach. 3D method was a better predictor of complications particularly in presence of upper septal hypertrophy. Finally, the Group of Leiden compared the echocardiographic results of a series of 80 patients treated with transcatheter aortic valve implantation (TAVR) vs
suturless valve prostheses implanted by surgery. TAVR showed a better haemodynamic results in terms of valvular area, gradients and lower mismatch than stenless prosthesis. However, the mid-term survival at 2 years was comparable in both groups.
The session finished with a state of the art remaking the impact of these excellent presentations in clinical practice.
State of the Art - Aortic stenosis: from epidemiology to treatment
© 2017 European Society of Cardiology. All rights reserved